Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 106,427
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Phone: 888-658-8287
wizeinvesting
wizeinvesting May. 21 at 8:41 AM
$SPLV $CEG $XLV $VHT $PPH While markets remain dominated by AI hype, high-growth narratives, and momentum-driven capital flows, a quieter rotation is beginning beneath the surface. Dividend ETFs—often overlooked during aggressive bull cycles—are now sitting in a rare position where many defensive income strategies have lagged despite stable fundamentals. This newsletter explores why funds like SPLV, XLV, VHT, PPH, and MORT may be entering a period where valuation compression, policy uncertainty, and interest-rate expectations create potential long-term opportunity zones for disciplined income investors. In a market obsessed with speed, the real shift may be happening in the segments that nobody is paying attention to right now. Inside the full breakdown, we dive into how healthcare uncertainty, interest-rate cycles, and defensive sector underperformance are reshaping dividend ETF valuations — and why some of the... https://www.wizeinvesting.com/p/494-in-5-years-the-long-term-energy-payoff
0 · Reply
StocktwitsNews
StocktwitsNews May. 12 at 7:31 PM
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief $REPL $QURE $PPH $IHE https://stocktwits.com/news/equity/markets/repl-qure-stocks-rise-amid-makary-reported-resignation-as-fda-chief/cZXXVRmReiy
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 2 at 11:35 PM
Trump Slaps 100% Tariffs On Imported Patented Drugs, Sparing Companies That Onshore Or Cut Prices $IHE $PPH https://stocktwits.com/news/equity/markets/trump-slaps-100-percent-tariffs-on-imported-patented-drugs/cZ7U7k5RI8v
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 2 at 3:35 PM
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report $SPY $DIA $PPH $IHE https://stocktwits.com/news/equity/markets/trump-new-100-pharma-tariffs-companies-no-deal-yet/cZ7xDpiRI8S
0 · Reply
jewell69
jewell69 Apr. 2 at 1:47 PM
Sintezza what is this ? $PPH
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 10:45 AM
$PPH Share Price: $101.91 Contract Selected: Oct 16, 2026 $110 Calls Buy Zone: $2.29 – $2.84 Target Zone: $3.85 – $4.71 Potential Upside: 59% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 19 at 3:59 PM
Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy $NVO $PPH $PVAL https://stocktwits.com/news/equity/markets/novo-nordisk-wegovy-hd-7-2-mg-approved-by-fda/cZ3aFJgRIhX
0 · Reply
Traveling_Trader87
Traveling_Trader87 Mar. 10 at 1:01 PM
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 10 at 1:01 PM
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-hims-deal-turns-wall-street-bullish-hims-stock-upgrades/cZdos7IRI7d
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 9 at 1:06 PM
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy $HIMS $NVO $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk
0 · Reply
Latest News on PPH
Britain agrees full text of US-UK pharmaceutical trade deal

Apr 2, 2026, 11:54 AM EDT - 2 months ago

Britain agrees full text of US-UK pharmaceutical trade deal

IHE PJP XPH


Final Trade: JCI, PPH, TOL, IBM

Oct 7, 2025, 6:19 PM EDT - 8 months ago

Final Trade: JCI, PPH, TOL, IBM

IBM JCI TOL


Final Trade: MSTR, PPH, TLT, MCD

Jan 7, 2025, 6:37 PM EST - 1 year ago

Final Trade: MSTR, PPH, TLT, MCD

MCD MSTR TLT


Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

Nov 16, 2023, 2:00 AM EST - 2 years ago

Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

BMY JNJ LLY PFE


Biotech Stocks Are Rallying, but the Outlook Isn't Good

Nov 15, 2023, 12:28 PM EST - 2 years ago

Biotech Stocks Are Rallying, but the Outlook Isn't Good

XBI XLV


3 ETFs in Focus as Race for Vaccine Intensifies

May 18, 2020, 10:03 AM EDT - 6 years ago

3 ETFs in Focus as Race for Vaccine Intensifies

PTH XBI


Best Performing Pharmaceutical ETFs for Q3 2020

May 13, 2020, 12:22 PM EDT - 6 years ago

Best Performing Pharmaceutical ETFs for Q3 2020

KURE XPH


wizeinvesting
wizeinvesting May. 21 at 8:41 AM
$SPLV $CEG $XLV $VHT $PPH While markets remain dominated by AI hype, high-growth narratives, and momentum-driven capital flows, a quieter rotation is beginning beneath the surface. Dividend ETFs—often overlooked during aggressive bull cycles—are now sitting in a rare position where many defensive income strategies have lagged despite stable fundamentals. This newsletter explores why funds like SPLV, XLV, VHT, PPH, and MORT may be entering a period where valuation compression, policy uncertainty, and interest-rate expectations create potential long-term opportunity zones for disciplined income investors. In a market obsessed with speed, the real shift may be happening in the segments that nobody is paying attention to right now. Inside the full breakdown, we dive into how healthcare uncertainty, interest-rate cycles, and defensive sector underperformance are reshaping dividend ETF valuations — and why some of the... https://www.wizeinvesting.com/p/494-in-5-years-the-long-term-energy-payoff
0 · Reply
StocktwitsNews
StocktwitsNews May. 12 at 7:31 PM
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief $REPL $QURE $PPH $IHE https://stocktwits.com/news/equity/markets/repl-qure-stocks-rise-amid-makary-reported-resignation-as-fda-chief/cZXXVRmReiy
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 2 at 11:35 PM
Trump Slaps 100% Tariffs On Imported Patented Drugs, Sparing Companies That Onshore Or Cut Prices $IHE $PPH https://stocktwits.com/news/equity/markets/trump-slaps-100-percent-tariffs-on-imported-patented-drugs/cZ7U7k5RI8v
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 2 at 3:35 PM
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report $SPY $DIA $PPH $IHE https://stocktwits.com/news/equity/markets/trump-new-100-pharma-tariffs-companies-no-deal-yet/cZ7xDpiRI8S
0 · Reply
jewell69
jewell69 Apr. 2 at 1:47 PM
Sintezza what is this ? $PPH
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 10:45 AM
$PPH Share Price: $101.91 Contract Selected: Oct 16, 2026 $110 Calls Buy Zone: $2.29 – $2.84 Target Zone: $3.85 – $4.71 Potential Upside: 59% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 19 at 3:59 PM
Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy $NVO $PPH $PVAL https://stocktwits.com/news/equity/markets/novo-nordisk-wegovy-hd-7-2-mg-approved-by-fda/cZ3aFJgRIhX
0 · Reply
Traveling_Trader87
Traveling_Trader87 Mar. 10 at 1:01 PM
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 10 at 1:01 PM
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-hims-deal-turns-wall-street-bullish-hims-stock-upgrades/cZdos7IRI7d
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 9 at 1:06 PM
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy $HIMS $NVO $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 6 at 10:23 PM
FDA Vaccine Chief Vinay Prasad To Exit Agency In April: Report $IHE $PPH https://stocktwits.com/news/equity/markets/fda-vaccine-chief-vinay-prasad-to-exit-agency-in-april-report/cZdLgVkRI4a
0 · Reply
goinbananas
goinbananas Mar. 6 at 5:58 PM
$MRK out for now, wrote it from the low 80s up to this level. Looking like a pullback is an inevitable in the short term. Still a nice PE though even here   $PPH $QQQ $SPY
0 · Reply
dany_u1
dany_u1 Feb. 27 at 6:41 PM
$NVO all pharma is well up (see $PPH), only this is down, very strange ... it will recover for sure
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 25 at 1:29 PM
Novo, Vivtex Ink $2.1 Billion Deal To Develop Oral Medicines For Obesity And Diabetes $NVO $LLY $OZEM $THNR $PPH https://stocktwits.com/news/equity/markets/novo-vivtex-deal-to-develop-oral-medicines-for-obesity-diabetes/cZRydmtRIGP
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 25 at 1:15 PM
Why Did GERN Stock Tumble 10% Pre-Market Today? $GERN $PPH $IYH https://stocktwits.com/news/equity/markets/why-did-gern-stock-tumble-9-pre-market-today/cZRydItRIG2
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 23 at 11:31 AM
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry $MRK $PPH $PJP $IYH https://stocktwits.com/news/equity/markets/merck-splitting-pharma-division-keytruda-patent-nears-2028-expiry/cZRt85ZR4yE
0 · Reply
chuckieclam
chuckieclam Feb. 23 at 10:16 AM
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 23 at 9:55 AM
Why Is NVO Stock Falling Pre-Market Today? $NVO $PPH $PVAL $AVDE $FTHI https://stocktwits.com/news/equity/markets/why-is-nvo-stock-falling-pre-market-today/cZRtZlKR4UC
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 1:13 AM
$PPH Current Stock Price: $110.95 Contracts to trade: $111.0 PPH Feb 20 2026 Call Entry: $0.35 Exit: $0.48 ROI: 38% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 12 at 10:21 AM
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
0 · Reply
TalkMarkets
TalkMarkets Feb. 9 at 8:08 PM
Wild Week Of Rotation: Sector Performance 2026 $PPH $SPY $XBI $XLV $ARKG https://talkmarkets.com/content/etfs/wild-week-of-rotation-sector-performance-2026?post=556147
0 · Reply